Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody

Clinical and Experimental Rheumatology

Volumn 27, Issue 5, 2009, Pages 888-889

  Bartoloni, E ^a   Alunno, A ^a   Luccioli, F ^a   Santoboni, G ^a   Gerli, R ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISONE; RITUXIMAB;

ADULT; ADULT ONSET STILL DISEASE; BACTERIAL PNEUMONIA; CASE REPORT; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET;

EID: 72949112982     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. KONTZIAS A, EFTHIMIOU P: Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 2008; 68: 319-337
2. EFTHIMIOU P, FLAVELL RA, FURLAN A et al.: Autoinflammatory sindrome and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S53-61.
3. KÖTTER I, WACKER A, KOCH S et al.: Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 2007; 37: 189-197
4. JEON YK, PAIK JH, PARK SS et al.: Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol 2004; 57: 1052-1056
5. JAMIN C, MORVA A, LEMOINE S, DARIDON C, REVOL DE MENDOZA A, YOUINOU P: Regulatory B lymphocytes in humans. A potential role in autoimmunity. Arthritis Rheum 2008; 58: 1900-1906
6. SONO H, MATSOU K, MIYAZATO H et al. A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma. Lupus 2000; 9: 468-70.
7. OTROCK Z, HATOUM H, UTHMAN I, TAHER A, SAAB S, SHAMSEDDINE A: Non-Hodgkin's lymphoma in a woman with adult-onset Still's disease: a case report. J Med Case Rep 2008; 2: 73.
8. GEURTS D, VAN DER VELDEN W, HEBEDA K, RAEMAEKERS J: Richter's syndrome developing in a patient with adult onset Still's disease. Ann Hematol 2009; 88: 81-84
9. LEQUERRÈ T, QUARTIER P, ROSELLlNI D et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Arm Rheum Dis 2008; 67: 302-308
10. YAMAGUCHI M, OHTA A, TSUNEMATSU T et al.: Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424-430
11. AHMADI-SIMAB K, LAMPRECHT P, JANKOWlAK C, GROSS WL: Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis 2006; 65: 1117-1118
12. NAKAHARA H, MIMA T, YOSHIO-HOSHINO N, MATSUSHITA M, HASHIMOTO J, NISHIMOTO N: A case report of a patient widi refractory adult- onset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 2009; 19: 69-72.
13. BANDT M, SAINT-MARCOUX B: Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009; 68: 153-154
14. PRIORI R, CECCARELLI F, BARONE F, IAGNOCCO A, VALESINI G: Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease. Clin Exp Rheumatol 2008; 26: 933-937
15. APPENZELLER S, CASTRO G, COSTALLAT L, SAMARA A, BERTOLO M: Adult-onset Still disease in southeast Brazil. J Clin Rheumatol 2005; 11: 76-80. (Pubitemid 40577951)
16. ARKFELD DG: The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 2008; 28: 205-215